Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 638K
2: EX-10.1 Material Contract HTML 43K
3: EX-10.2 Material Contract HTML 60K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 23K
14: R1 Document and Entity Information HTML 40K
15: R2 Condensed Consolidated Balance Sheets HTML 100K
16: R3 Condensed Consolidated Balance Sheets HTML 30K
(Parenthetical)
17: R4 Condensed Consolidated Statements of Operations HTML 85K
18: R5 Condensed Consolidated Statements of Comprehensive HTML 41K
Loss
19: R6 Condensed Consolidated Statements of Cash Flows HTML 138K
20: R7 Business and Organization HTML 29K
21: R8 Summary of Significant Accounting Policies HTML 79K
22: R9 Earnings (Loss) Per Share HTML 29K
23: R10 Composition of Certain Financial Statement HTML 122K
Captions
24: R11 Acquisitions, Investments and Licenses HTML 61K
25: R12 Debt HTML 128K
26: R13 Accumulated Other Comprehensive Income (Loss) HTML 38K
27: R14 Fair Value Measurements HTML 138K
28: R15 Derivative Contracts HTML 54K
29: R16 Related Party Transactions HTML 36K
30: R17 Commitments and Contingencies HTML 35K
31: R18 Strategic Alliances HTML 51K
32: R19 Segments HTML 153K
33: R20 Subsequent Events HTML 27K
34: R21 Summary of Significant Accounting Policies HTML 137K
(Policies)
35: R22 Composition of Certain Financial Statement HTML 123K
Captions (Tables)
36: R23 Acquisitions, Investments and Licenses (Tables) HTML 48K
37: R24 Debt (Tables) HTML 107K
38: R25 Accumulated Other Comprehensive Income (Loss) HTML 38K
(Tables)
39: R26 Fair Value Measurements (Tables) HTML 139K
40: R27 Derivative Contracts (Tables) HTML 56K
41: R28 Segments (Tables) HTML 151K
42: R29 Business and Organization (Details) HTML 34K
43: R30 Summary of Significant Accounting Policies HTML 134K
(Details)
44: R31 Earnings (Loss) Per Share - Narrative (Details) HTML 33K
45: R32 Composition of Certain Financial Statement HTML 138K
Captions (Details)
46: R33 Composition of Certain Financial Statement HTML 57K
Captions - Changes in Goodwill (Details)
47: R34 Acquisitions, Investments and Licenses - HTML 32K
Acquisition Narrative (Details)
48: R35 Acquisitions, Investments and Licenses - HTML 44K
Transition Therapeutics Purchase Price Allocation
(Details)
49: R36 Acquisitions, Investments and Licenses - Summary HTML 37K
of Investments (Details)
50: R37 Acquisitions, Investments and Licenses - Equity HTML 60K
and Cost Method Investments Narrative (Details)
51: R38 Acquisitions, Investments and Licenses - Available HTML 55K
for Sale Investments, Sale of Investments and
Warrants and Options Narrative (Details)
52: R39 Acquisitions, Investments and Licenses - Variable HTML 33K
Interest Entities Narrative (Details)
53: R40 Acquisitions, Investments and Licenses - Other HTML 40K
Narrative (Details)
54: R41 Debt - Narrative (Details) HTML 166K
55: R42 Debt - Notes (Details) HTML 53K
56: R43 Debt - Inputs Used In Lattice Model (Details) HTML 40K
57: R44 Debt - Lines Of Credit (Details) HTML 60K
58: R45 Debt - Mortgage Notes And Other Debt (Details) HTML 31K
59: R46 Accumulated Other Comprehensive Income (Loss) HTML 43K
(Details)
60: R47 Fair Value Measurements - Summary Of Investments HTML 35K
(Details)
61: R48 Fair Value Measurements - Assets And Liabilities HTML 75K
Measured At Fair Value (Details)
62: R49 Fair Value Measurements - Notes HTML 33K
63: R50 Fair Value Measurements - Level 3 Reconciliation HTML 38K
(Details)
64: R51 Fair Value Measurements - Narrative (Details) HTML 33K
65: R52 Derivative Contracts - Balance Sheet Component HTML 39K
(Details)
66: R53 Derivative Contracts - Derivative Gains (Losses) HTML 33K
(Details)
67: R54 Related Party Transactions (Details) HTML 172K
68: R55 Commitments and Contingencies (Details) HTML 49K
69: R56 Strategic Alliances (Details) HTML 106K
70: R57 Segments - Narrative (Details) HTML 42K
71: R58 Segments - Operations and Assets Information HTML 78K
(Details)
72: R59 Subsequent Events (Details) HTML 31K
74: XML IDEA XML File -- Filing Summary XML 128K
73: EXCEL IDEA Workbook of Financial Reports XLSX 106K
8: EX-101.INS XBRL Instance -- opk-20170930 XML 2.78M
10: EX-101.CAL XBRL Calculations -- opk-20170930_cal XML 242K
11: EX-101.DEF XBRL Definitions -- opk-20170930_def XML 1.02M
12: EX-101.LAB XBRL Labels -- opk-20170930_lab XML 1.96M
13: EX-101.PRE XBRL Presentations -- opk-20170930_pre XML 1.23M
9: EX-101.SCH XBRL Schema -- opk-20170930 XSD 188K
75: ZIP XBRL Zipped Folder -- 0000944809-17-000018-xbrl Zip 302K
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Frost, Chief Executive Officer of OPKO Health, Inc. (the “Company”), hereby certify that:
The Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2017 (the “Form 10-Q”) of the
Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
